You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 11, 2025

Details for Patent: 8,642,079


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,642,079 protect, and when does it expire?

Patent 8,642,079 protects OSPHENA and is included in one NDA.

This patent has twenty-four patent family members in eighteen countries.

Summary for Patent: 8,642,079
Title:Solid formulations of ospemifene
Abstract: This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) ##STR00001## or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.
Inventor(s): Lehtola; Veli-Matti (Turku, FI), Halonen; Kaija (Rusko, FI)
Assignee: Hormos Medical Corporation (Turku, FI)
Application Number:10/783,024
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,642,079
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,642,079

Introduction

United States Patent 8,642,079 is a significant patent in the pharmaceutical sector, and understanding its scope and claims is crucial for anyone involved in drug development, intellectual property, or related fields. Here, we will delve into the details of this patent, including its claims, specifications, and the broader patent landscape.

Patent Overview

Document Number and Type

The patent number is 8,642,079, indicated by the "10" INID code, which signifies that it is a U.S. patent. The "B2" code following the number indicates that this patent has a previously published application[1].

Application and Patent Dates

The patent was applied for on a specific date (indicated by the "22" INID code) and was granted on the date listed under the "45" INID code. These dates are critical for understanding the timeline and validity of the patent.

Title and Abstract

The title of the invention (limited to 500 characters or less) provides a concise description of what the patent covers. The abstract offers a brief, non-technical description of the invention, giving a general overview of its purpose and scope[1].

Claims

Definition and Purpose

The claims section is perhaps the most critical part of a patent, as it defines the scope of protection. Claims are paragraphs located at the end of the specification and are preceded by phrases such as “I claim” or “What is claimed.” These claims legally define the boundaries of the invention, similar to how a property deed defines physical boundaries[1].

Claims Structure

Patent 8,642,079 includes multiple claims, each detailing specific aspects of the invention. Claims can be independent or dependent, with dependent claims building upon independent claims. The structure of these claims is crucial for determining what is protected under the patent.

Specification

Description of the Invention

The specification is a detailed written description of the invention. It includes discussions of related prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. This section must provide enough detail so that anyone with ordinary skill in the same technical field can understand and replicate the invention[1].

Drawings and Illustrations

The drawings section contains black and white drawings that illustrate the technical details of the invention. These drawings must conform to drafting guidelines set by the patent office and are labeled clearly to provide sufficient detail for understanding the invention’s design and use[1].

Patent Landscape

International and National Classifications

The patent is classified under various international and national systems, such as the International Patent Classification (IPC) and the U.S. National Classification system. For example, the IPC classification helps in categorizing the patent within a broader global context[1].

Prior Art and References

The patent includes references to U.S. and foreign patent documents and other publications cited as related prior art by the inventor and patent examiner. This section is important for understanding the existing knowledge in the field and how the current invention differs from or builds upon previous work[1].

Assignee and Inventors

Ownership and Inventorship

The assignee, listed under the "73" INID code, is the owner of the patent at the time it was issued. This can be a person, company, or organization. The inventors, listed under the "72" INID code, are the individuals who created the invention[1].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including those granted between 1976 and 2014. This dataset can be used to analyze trends and measurements of patent scope, which is relevant for understanding the broader impact of patents like 8,642,079[3].

Search and Analysis Tools

USPTO Search Tools

To analyze the patent landscape, tools such as the Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used. These tools provide access to prior art, file histories, and citation data, which are essential for conducting thorough patent searches and analyses[4].

Expiration and Generic Entry

Patent Expiration

The expiration date of the patent is crucial for understanding when generic versions of the drug can enter the market. For patent 8,642,079, the expiration date and any term adjustments due to processing delays are important factors[5].

Key Takeaways

  • Claims Definition: The claims section is critical and defines the legal boundaries of the invention.
  • Specification Detail: The specification must provide enough detail for anyone with ordinary skill in the field to understand and replicate the invention.
  • Patent Landscape: Understanding the international and national classifications, prior art, and references is essential for placing the patent within the broader context.
  • Ownership and Inventorship: Knowing the assignee and inventors is important for legal and commercial purposes.
  • Expiration Dates: The expiration date of the patent affects when generic versions can enter the market.

FAQs

Q: What is the purpose of the claims section in a patent? A: The claims section defines the scope of protection for the invention, outlining what is legally protected under the patent.

Q: How do drawings contribute to the understanding of a patent? A: Drawings illustrate the technical details of the invention, providing clear and detailed visual representations that complement the written specification.

Q: What is the significance of the IPC classification in a patent? A: The IPC classification helps categorize the patent within a global context, making it easier to search and compare similar inventions internationally.

Q: How can one determine the expiration date of a patent? A: The expiration date can be found in the patent document or through databases like the FDA Orange Book or other patent search tools.

Q: What tools are available for searching and analyzing patent data? A: Tools such as the Patent Public Search, Global Dossier, and Common Citation Document (CCD) are available for searching and analyzing patent data.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. Drugpatentwatch.com: Pharmaceutical drugs covered by patent 8,642,079.
  3. USPTO.gov: Patent Claims Research Dataset - USPTO.
  4. USPTO.gov: Search for patents - USPTO.
  5. Pharmacompass.com: US Patent 8642079 | US Patents | Expiry | Expiration | Dates.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,642,079

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Duchesnay OSPHENA ospemifene TABLET;ORAL 203505-001 Feb 26, 2013 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 8,642,079

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2005215174 ⤷  Subscribe
Austria E506054 ⤷  Subscribe
Brazil PI0507897 ⤷  Subscribe
Canada 2554695 ⤷  Subscribe
China 1953741 ⤷  Subscribe
Cyprus 1111689 ⤷  Subscribe
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.